BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 6365414)

  • 1. Review of cefonicid, a long-acting cephalosporin.
    Dudley MN; Quintiliani R; Nightingale CH
    Clin Pharm; 1984; 3(1):23-32. PubMed ID: 6365414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects.
    Pontzer RE; Kaye D
    Pharmacotherapy; 1984; 4(6):325-33. PubMed ID: 6393074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E; Brogden RN
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of cefonicid in the treatment of staphylococcal infections.
    Lentnek AL; Evrard HM; Wikler MA; Sohn CA; Phillips SW
    Clin Ther; 1985; 7(6):725-32. PubMed ID: 4075363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of long-acting cephalosporins in ambulatory therapy.
    Prichard JG
    Clin Ther; 1988; 10(6):688-93. PubMed ID: 3219684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Campoli-Richards DM; Lackner TE; Monk JP
    Drugs; 1987 Oct; 34(4):411-37. PubMed ID: 3315624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
    Hamilton-Miller JM; Patel R; Brumfitt W
    Drugs Exp Clin Res; 1986; 12(11):861-9. PubMed ID: 3816503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
    Tartaglione TA; Polk RE
    Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cefonicid and cefoxitin for preventing infections after vaginal hysterectomy.
    Mercer LJ; Murphy HJ; Ismail MA; Hajj SN
    J Reprod Med; 1988 Feb; 33(2):223-6. PubMed ID: 3351823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
    Chemioterapia; 1987 Apr; 6(2):95-8. PubMed ID: 3594635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
    Chanal M; Cluzel M; Sirot D; Joly B; Sirot J; Cluzel R
    Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefonicid vs. cefoxitin for cesarean section prophylaxis.
    Hartert RA; Benrubi G; Thompson RJ; Nuss RC
    J Reprod Med; 1987 Dec; 32(12):907-10. PubMed ID: 3430499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefonicid: an overview of clinical studies in the United States.
    Jacob LS; Layne P
    Rev Infect Dis; 1984; 6 Suppl 4():S791-802. PubMed ID: 6395272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M; Deamer RL; Prichard JG
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of cefonicid sodium versus cefoxitin sodium for the prevention of postoperative infections after nonelective cesarean section.
    Briggs GG; Moore BR; Bahado-Singh R; Lange S; Bogh P; Garite TJ
    Clin Pharm; 1987 Sep; 6(9):718-21. PubMed ID: 3119278
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies of multiple-dose cefoxitin vs. single-dose cefonicid for surgical prophylaxis in patients undergoing biliary tract operations or hysterectomy.
    Maki DG; Lammers JL; Aughey DR
    Rev Infect Dis; 1984; 6 Suppl 4():S887-95. PubMed ID: 6395279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceforanide: antibacterial activity, pharmacology, and clinical efficacy.
    Barriere SL; Mills J
    Pharmacotherapy; 1982; 2(6):322-7. PubMed ID: 6762529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose cefazolin versus cefonicid for antibiotic prophylaxis in cesarean delivery.
    Duff P; Robertson AW; Read JA
    Obstet Gynecol; 1987 Nov; 70(5):718-21. PubMed ID: 3658278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro experience with cefonicid.
    Actor P
    Rev Infect Dis; 1984; 6 Suppl 4():S783-90. PubMed ID: 6522920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.